FDA 483 - Teva Biotech GmbH - March 13, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Teva Biotech GmbH in Ulm, Germany, a drug substance manufacturer, was cited for significant deficiencies across its manufacturing processes, laboratory controls, and facility maintenance. The inspection revealed issues with process validation, facility design, data integrity, adherence to and adequacy of procedures, and various qualification and validation activities. These observations indicate a broad range of concerns regarding the firm's ability to ensure the quality and integrity of its drug substance products.
ID · c32721c7-3cb1-4441-979b-735e8d352d8e